11072169

Source:http://linkedlifedata.com/resource/pubmed/id/11072169

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0079746, umls-concept:C1306673, umls-concept:C1314939, umls-concept:C1512863, umls-concept:C1521738, umls-concept:C1522449
pubmed:issue	4
pubmed:dateCreated	2000-11-27
pubmed:abstractText	To analyze the impact of involved field radiotherapy on local control, freedom from progression, and overall survival in patients with clinical Stage III-IV, intermediate grade, or large-cell immunoblastic lymphomas that responded to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)-based induction chemotherapy.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA 16672, http://linkedlifedata.com/resource/pubmed/grant/CA 6294
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0360-3016
pubmed:author	pubmed-author:CabanillasF FFF, pubmed-author:HaC SCS, pubmed-author:KUTILL, pubmed-author:PalN KNK, pubmed-author:RodriguezM AMA, pubmed-author:SchlembachP JPJ, pubmed-author:TuckerS LSL, pubmed-author:WilderR BRB
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	48
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1107-10
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:11072169-Adult, pubmed-meshheading:11072169-Aged, pubmed-meshheading:11072169-Aged, 80 and over, pubmed-meshheading:11072169-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11072169-Combined Modality Therapy, pubmed-meshheading:11072169-Cyclophosphamide, pubmed-meshheading:11072169-Disease Progression, pubmed-meshheading:11072169-Doxorubicin, pubmed-meshheading:11072169-Follow-Up Studies, pubmed-meshheading:11072169-Humans, pubmed-meshheading:11072169-Lymphoma, Large-Cell, Immunoblastic, pubmed-meshheading:11072169-Lymphoma, Non-Hodgkin, pubmed-meshheading:11072169-Middle Aged, pubmed-meshheading:11072169-Neoplasm Staging, pubmed-meshheading:11072169-Prednisone, pubmed-meshheading:11072169-Prognosis, pubmed-meshheading:11072169-Proportional Hazards Models, pubmed-meshheading:11072169-Prospective Studies, pubmed-meshheading:11072169-Vincristine
pubmed:year	2000
pubmed:articleTitle	Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
pubmed:affiliation	Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S.